A Study of Golimumab in Participants With Active Psoriatic Arthritis

Clinical trial NCT02181673 · COMPLETED

Trial details

NCT number: NCT02181673
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis, Psoriatic

Start date: 2014-09-08
Primary completion: 2016-05-05
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.